Search

everythinglearnresearchcommunity

for

Search:↓

The device applies substances directly to body tissues, improving cell transplant and treatment processes.

An adult with a rare skin condition improved with tazarotene treatment.

Radiation damages hair stem cells and changes keratin expression, with Krt5 as a potential marker for radiation effects.

A rare skin condition usually on the face was found on a man's heel.

A new skin treatment using a patient's own cells healed chronic wounds effectively and was preferred over traditional grafts.

Androgens can cause acne, excess hair, and hair loss, treatable with dermatologist-guided therapies.

People with alopecia areata have similar retinal structures but thicker choroidal regions compared to those without the condition.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Keratin treatment reduces astrocyte reactivity and inflammation.

Hair loss in this case was caused by a tumor, not typical baldness.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Keratins 8 and 14 can help identify and diagnose benign skin tumors.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

RCS-01 cell therapy is safe and improves skin gene expression.

EGFR deficiency in skin causes hair follicle issues and inflammation.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Acitretin helped improve hand mobility and skin condition in a patient.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

OCT can non-invasively diagnose follicular keratosis and other hair follicle disorders.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

A man's red tattoo caused a skin reaction and hair loss in his beard, which improved after treatment.

PAON shows skin patterns due to genetic mosaicism.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.